TheraBreath Launches Alcohol-Free Fluoride Toothpaste with Clinical Benefits
EWING, N.J., August 19, 2025 — TheraBreath™, the best-selling alcohol-free mouthwash brand in the U.S., has introduced a new...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
EWING, N.J., August 19, 2025 — TheraBreath™, the best-selling alcohol-free mouthwash brand in the U.S., has introduced a new...
NORTH CHICAGO, IL. and SAN DIEGO, CA, August 19, 2025 – AbbVie (NYSE: ABBV) and Capstan Therapeutics, Inc. (“Capstan”),...
SOUTH SAN FRANCISCO, Calif., August 19, 2025 – Convoke, an AI-native operating system for the biopharmaceutical industry, today announced...
Hong Kong, August 20, 2025 — Akeso, Inc. (9926.HK) has announced the enrollment and dosing of the first patient...
July 10, 2025 – The U.S. Food and Drug Administration (FDA) has approved BRAVECTO® QUANTUM (fluralaner for extended-release injectable...
August 7, 2025 – The U.S. Food and Drug Administration (FDA) has announced the launch of FDA PreCheck, a...
Research Triangle Park, NC & Pleasanton, CA – August 20, 2025 – After years of high-profile legal battles, life...
Mahwah, New Jersey, August 19, 2025 – Glenmark Pharmaceuticals Inc., USA is set to introduce Micafungin for Injection USP...
August 19, 2025 — Germantown, MD – Precigen, Inc. (NASDAQ: PGEN) today announced that the U.S. Food and Drug...
Portland, Oregon – August 14, 2025 – In what marks the largest single donation ever made to a U.S....
